> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears CereMetrix Neuroimaging Analytics Platform
- URL: https://www.fdaweb.com/fda-clears-ceremetrix-neuroimaging-analytics-platform/
- Published: 2018-03-13T12:00:00.000Z
- Updated: 2026-09-14T23:53:00.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5140965

FDA has cleared a CereMetrix 510(k) for its neuroimaging analytics and quantification platform CereMetrix Silver. The device allows healthcare providers to have access to objective neuroimaging that detects, quantifies and analyzes brain function down to the voxel level, according to the company. The image viewer is designed to analyze brain imaging, including PET, SPECT, MRI and CT scans, and can “allow for the localization and definition of brain function and differentiate between hyper (more than average) and hypo (less than average) function in the brain,” it says.